title: Cost-effective treatment for the couple with infertility.
abstract: Although the evaluation of cost-effective approaches to infertility treatment remains in its infancy, several important principles have emerged from the initial studies in this field. Currently, in treating couples with infertility without tubal disease or severe male-factor infertility, the most cost-effective approach is to start with IUI or superovulation-IUI treatments before resorting to IVF procedures. The woman's age and number of sperm present for insemination are significant factors influencing cost-effectiveness. The influence of certain diagnoses on the cost-effectiveness of infertility treatments requires further study. Even when accounting for the costs associated with multiple gestations and premature deliveries, the cost of IVF decreases within the range of other cost-effective medical procedures and decreases to less than the willingness to pay for these procedures. Indeed, for patients with severe tubal disease, IVF has been found to be more cost-effective than surgical repair. The cost-effectiveness of IVF will likely improve as success rates show continued improvements over the course of time. In addition, usefulness of embryo selection and practices to reduce the likelihood of high-order multiple pregnancies, without reductions in pregnancy rates, will significantly impact cost-effectiveness. The exclusion of infertility treatments from insurance plans is unfortunate and accentuates the importance of physicians understanding the economics of infertility treatment with costs that are often passed directly to the patient. The erroneous economic policies and judgments that have led to inequities in access to infertility health care should not be tolerated.
authors: University of Iowa Hospitals and Clinics, Department of Obstetrics and Gynecology, Iowa City 52245, USA. brad-van-voorhis@uiowa.edu
authors: B J
authors: BJ
authors: Van Voorhis
authors: C H
authors: CH
authors: Syrop
mesh_terms: D003362:Cost-Benefit Analysis; D005260:Female; D005307:Fertilization in Vitro / Q000191:economics*; D006801:Humans; D007247:Infertility, Female / Q000191:economics / Q000628:therapy*; D007248:Infertility, Male / Q000191:economics / Q000628:therapy*; D008297:Male; D011247:Pregnancy; D014481:United States